ResearchMoz presents this most up-to-date research on "Cancer Pain Therapeutics In Global Market: Pharmaceutical Interventions such As Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, And Adjuvant Pain Medications, 2015 - 2019".
Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual's body. Pain control is imperative not only for people who have advanced cancer but also for those whose condition remains stable for years. Pharmaceutical interventions such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant pain medications are used to treat cancer pain.
Technavios analysts forecast the global cancer pain therapeutics market to grow at a CAGR of 9.08% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cancer pain therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of cancer pain.
The market is divided into the following segments based on region:
Americas: The US, Canada, Mexico, and Brazil
EMEA: The UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
APAC: Japan, China, Australia, Singapore, South Korea, and India
Technavio's report, Global Cancer Pain Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
BioDelivery Sciences
ProStrakan Group
Teva Pharmaceuticals
Yamaha
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=527118
Other prominent vendors
Daiichi Sankyo
Eli-lilly
Galena Biopharma
Grunenthal Group
GW Pharmaceuticals
Hospira
Johnson & Johnson
Meda Pharmaceuticals
Orexo
Sanofi
Sorrento Therapeutics
WEX Pharmaceuticals
Market driver
Unmet medical needs
For a full, detailed list, view our report
Market challenge
Off-label drug use
For a full, detailed list, view our report
Market trend
Increase in awareness
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=527118
Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual's body. Pain control is imperative not only for people who have advanced cancer but also for those whose condition remains stable for years. Pharmaceutical interventions such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant pain medications are used to treat cancer pain.
Technavios analysts forecast the global cancer pain therapeutics market to grow at a CAGR of 9.08% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cancer pain therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of cancer pain.
The market is divided into the following segments based on region:
Americas: The US, Canada, Mexico, and Brazil
EMEA: The UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
APAC: Japan, China, Australia, Singapore, South Korea, and India
Technavio's report, Global Cancer Pain Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
BioDelivery Sciences
ProStrakan Group
Teva Pharmaceuticals
Yamaha
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=527118
Other prominent vendors
Daiichi Sankyo
Eli-lilly
Galena Biopharma
Grunenthal Group
GW Pharmaceuticals
Hospira
Johnson & Johnson
Meda Pharmaceuticals
Orexo
Sanofi
Sorrento Therapeutics
WEX Pharmaceuticals
Market driver
Unmet medical needs
For a full, detailed list, view our report
Market challenge
Off-label drug use
For a full, detailed list, view our report
Market trend
Increase in awareness
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=527118
